CD8A and lymphoma: The results clearly indicated that T cells from HIV+ patients at stages 2 and 3, irrespective of the presence of lymphoma, as well as from EBV+HIV+ patients, have an EBV-specific T cell response of lower quality because they lack mono- and multifunctional CD4+ and CD8+ T cells.